Contaminants and Natural Toxicants Subcommittee Meeting

Enterobacter sakazakii Contamination in Powdered Infant Formula

March 18-19, 2003

 

Tentative Agenda

 

March 18

 

8:00 – 8:30            Welcome, Introduction and Charges – Christine J. Taylor, FDA

 

8:30 – 8:45            Administrative Issues - Jeanne Latham, FDA

 

8:45 – 9:15            Remarks by Chairpersons

 

9:15 – 3:45            Presentations by Guest Speakers

 

9:15 – 9:45            Tennessee outbreak investigation - Matthew Kuehnert, CDC

 

9:45 – 10:15   Other relevant investigations - Karl Klontz, FDA

 

10:15 – 10:30            Break

 

10:30 – 11:00            How individuals respond/Long term, chronic consequences – John Alexander, FDA

 

11:00 – 11:30            Questions to speakers

 

11:30 – 12:30            Lunch

 

12:30 – 1:00     General Microbiology, e.g., ecology, pathogenicity, subtyping, etc. 

             Maria Nazarowec-White, Canada

 

1:00 – 1:30            Preliminary Subcommittee Discussion on Clinical Presentations   

 

1:30 – 2:00            Microbial detection, clinical and food - Don Burr, FDA

 

2:00 – 2:30            Resistance – Thermal and other - Robert Buchanan, FDA

 

2:30 – 2:45            Break

 

2:45 – 3:15            Manufacturing process, microbial standards, summary of FDA field survey - Don Zink, FDA

 

3:15 – 3:45            Current marketing and use of powdered infant formula - Sue Ann Anderson, FDA

 

3:45 – 4:00            Questions to speakers

 

4:00 – 5:00            Public Comment

 

5:00 – 6:00            Preliminary Discussion by Subcommittee

 

 

 

 

 

March 19

 

8:30 – 8:45            Opening Remarks

 

8:45 – 11:30            Subcommittee Discussion of Issues

 

10:00 - 10:15            Break

 

11:30 – 12:30            Lunch

 

12:30 – 3:00     Subcommittee Concluding Deliberations, Recommendations and Response to Charges